中国骨与关节杂志2024,Vol.13Issue(5) :396-400.DOI:10.3969/j.issn.2095-252X.2024.05.014

miR-26a对骨肉瘤发生转移及治疗作用的研究进展

Research progress of miR-26a on metastasis and treatment of osteosarcoma

李广渝 王旭东 李明
中国骨与关节杂志2024,Vol.13Issue(5) :396-400.DOI:10.3969/j.issn.2095-252X.2024.05.014

miR-26a对骨肉瘤发生转移及治疗作用的研究进展

Research progress of miR-26a on metastasis and treatment of osteosarcoma

李广渝 1王旭东 1李明1
扫码查看

作者信息

  • 1. 050000 石家庄,河北医科大学第二医院骨科
  • 折叠

Abstract

Osteosarcoma represents the most common form of bone malignant tumor with strong aggressiveness,easy metastasis,and chemotherapy resistance.The pathogenesis of osteosarcoma is yet to be fully elucidated.MicroRNAs are classified as noncoding small RNA with a length of 20-22 nucleotides,which are abnormally expressed in a variety of malignant tumors.miR-26a is an important member of the MicroRNA family,and its expression has been found to be associated with the occurrence,development,invasion,metastasis and drug resistance of osteosarcoma.Mechanism of miR-26a in osteosarcoma has important clinical significance for the diagnosis,treatment and prognosis of osteosarcoma.This article reviews the effects of miR-26a on the occurrence,development,invasion,metastasis and drug resistance of osteosarcoma,which provides a reference for the diagnosis and prediction of osteosarcoma.

关键词

骨肉瘤/微RNA/抗药性,肿瘤/miR-26a/综述

Key words

Osteosarcoma/miRNA/Drug resistance,neoplasm/miR-26a/Review

引用本文复制引用

基金项目

河北省自然科学基金(H2021206321)

出版年

2024
中国骨与关节杂志
中国医疗保健国际交流促进会,北京中科康辰骨关节伤病研究所

中国骨与关节杂志

CSTPCD
影响因子:0.665
ISSN:2095-252X
参考文献量1
段落导航相关论文